Associate Professor at Biopharmaceutics, Jordan University of Science & Technology, Jordan
Your remarkable academic journey, extensive research contributions, and dedication to the field of psychology are truly commendable. Your wealth of knowledge and diverse skill set reflect a deep commitment to understanding and addressing critical issues such as bullying, inclusion, and socialization.
π¬ Your successful completion of a PhD in Psychology, along with the numerous advanced courses and workshops, showcases your continuous pursuit of excellence and expertise in your field.
π The awards and recognitions, including the First Place in the Poster Award at the University of Stavanger, underscore the impact of your research and the high regard it holds in the academic community.
Professional Profiles:
Education:
Dr. Motasem Alsmadi is an Associate Professor of Biopharmaceutics and Pharmacokinetics with a joint appointment between the Nanotechnology Institute and the Pharmaceutical Technology Department at Jordan University of Science and Technology (J.U.S.T). He earned his BSc in Pharmacy, ranking first in his class, from J.U.S.T in 2009. Subsequently, he pursued graduate studies in Pharmaceutical Technology at The University of Iowa, completing his Ph.D. in December 2014. Afterward, he worked as an Assistant Professor of Pharmaceutical Technology at the Pharmacy School at J.U.S.T until September 2020, during which time he also served as an Assistant Dean at the Pharmacy School and the Graduate Studies School.
In September 2020, Dr. Alsmadi was promoted to an Associate Professor, and in January 2023, he was appointed as a Joint Professor in the Nanotechnology Institute. In this capacity, he taught graduate-level courses and supervised master’s students at the Nanotechnology Institute, in addition to his involvement in teaching undergraduate (B.Sc and Pharm D.) and graduate (MSc and Ph.D.) courses and supervising master’s students at the Pharmacy School. Dr. Alsmadi also served as a member of the JFDA Bioavailability and Bioequivalence Committee for two years (10/2019-10/2021) as part of his national service.
Academic/Professional Particulars:
Dr. Motasem Alsmadi specializes in Pharmaceutics/Biopharmaceutics and Pharmacokinetics, as well as Nanomedicine and in vivo safety and toxicokinetics of drug delivery systems. His academic qualifications include a Ph.D. in Pharmaceutics from the University of Iowa, USA, awarded in 2014. His dissertation was titled “Physiologically based pharmacokinetic (PBPK) model of Ivermectin (IVM),” and he achieved a GPA of 3.84. Dr. Alsmadi also holds a BSc in Pharmacy from Jordan University of Science and Technology, Jordan, awarded in 2008, where he ranked 1st in his batch. In terms of academic honors and awards, Dr. Alsmadi ranked 1st in the 2003 batch of BSc. in Pharmacy at Jordan University of Science and Technology from 2003 to 2008.
Mo’tasem Alsmadi ‘s citation metrics and indices from Google Scholar are as follows:
- Cited by: All: 208, Since 2018: 208
- Citations: 208 (All), 208 (Since 2018)
- h-index: 9 (All), 9 (Since 2018)
- i10-index: 7 (All), 7 (Since 2018)
These metrics showcase the impact of Alsmadi ‘s work within the academic community, demonstrating the number of citations his publications have received and the influence of his research output.
Research:
Dr. Motasem Alsmadi’s research interests include Physiologically-based Pharmacokinetics, Biopharmaceutics and Pharmacokinetics, and Nanomedicine, with a focus on in vivo safety and toxicokinetics of drug delivery systems. In terms of publications and citations, he has authored 17 articles in international refereed journals and presented 2 conference papers. His work has garnered 147 citations on Google Scholar. Dr. Alsmadi has also been involved in securing research grants, including the Local University Fund for Masterβs Thesis, where he serves as the Principal Investigator for the project “Formulation and evaluation of oral administration of cilnidipine nanocrystals for treatment of Hypertension diseases by enhancing solubility and dissolution rate” at Jordan University of Science and Technology (07/2023 β Present), with a funding of USD 7,700. Additionally, he has been a Co-Investigator for another project titled “Physiologically-Based Pharmacokinetics of a Novel Hydroxychloroquine Formulation Prepared Using Supercritical Fluid Technology for Pulmonary Administration” at Jordan University of Science and Technology (08/2021 β 01/2023), with a funding of USD 8,000.
Teaching:
Dr. Motasem Alsmadi has taught several courses, including Nano 700: Introduction to Nanoscience and Nanotechnology (taught once, excellent evaluation), Phar456: Bio Pharmaceutics and Pharmacokinetics (taught fourteen times, excellent evaluations), Phar 553: Clinical Pharmacokinetics (For Pharm D Students) (taught fifteen times, excellent evaluations), Phar401: Pharmaceutical Practical Training (taught three times, excellent evaluations), Phar 402: Community Pharmacy (For Pharm.D Students) (taught twice, excellent evaluations), and Phar 351: Pharmaceutics 1 (taught once, excellent evaluation). This demonstrates Dr. Alsmadi’s extensive experience in teaching a variety of pharmaceutical and pharmacokinetics courses, consistently earning high evaluations from his students.
Publications:
Preparation of hybrid alginate-chitosan aerogel as potential carriers for pulmonary drug delivery
- Published in Energy in 2020 with 38 citations.
Development,Β In VitroΒ Characterization, andΒ In VivoΒ Toxicity Evaluation of Chitosan-Alginate Nanoporous Carriers Loaded with Cisplatin for Lung Cancer Treatment
- Published in Energy in 2020 with 34 citations.
Enhancement of the dissolution and bioavailability from freeze-dried powder of a hypocholesterolemic drug in the presence of Soluplus
- Published in Energy in 2018 with 18 citations.
Pharmacy education in Jordan: updates
- Published in Energy in 2017 with 17 citations.
Optimization of drugs pharmacotherapy during pregnancy using physiologically based pharmacokinetic models-an update
- Published in Energy in 2018 with 14 citations.
Sublingual spray drug delivery of ketorolac-loaded chitosan nanoparticles
- Published in Energy in 2018 with 14 citations.